Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	histone methyltransferase complex	PHF20 KMT2A BOD1L1 PRDM4 HCFC1	2.11e-05	75	93	5	GO:0035097
GeneOntologyCellularComponent	axon	SLC12A6 CNTN4 RIN3 DRD2 SHANK2 CLCN3 MAP1B TRPC5 BRSK1 CBL SLC1A1 DICER1 DSCAML1 HCFC1	3.81e-05	891	93	14	GO:0030424
GeneOntologyCellularComponent	methyltransferase complex	PHF20 KMT2A BOD1L1 PRDM4 HCFC1	1.21e-04	108	93	5	GO:0034708
GeneOntologyCellularComponent	distal axon	DRD2 SHANK2 CLCN3 MAP1B TRPC5 BRSK1 CBL SLC1A1 DICER1	1.38e-04	435	93	9	GO:0150034
GeneOntologyCellularComponent	MLL1 complex	PHF20 KMT2A HCFC1	3.85e-04	32	93	3	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	PHF20 KMT2A HCFC1	4.22e-04	33	93	3	GO:0044665
GeneOntologyCellularComponent	histone acetyltransferase complex	PHF20 SUPT7L KAT6A HCFC1	8.25e-04	94	93	4	GO:0000123
GeneOntologyCellularComponent	NSL complex	PHF20 HCFC1	1.05e-03	11	93	2	GO:0044545
GeneOntologyCellularComponent	protein acetyltransferase complex	PHF20 SUPT7L KAT6A HCFC1	1.20e-03	104	93	4	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	PHF20 SUPT7L KAT6A HCFC1	1.43e-03	109	93	4	GO:1902493
GeneOntologyCellularComponent	caveola	AKAP6 LIPE CBL VDR	1.53e-03	111	93	4	GO:0005901
GeneOntologyCellularComponent	postsynapse	DRD2 SHANK2 CLCN3 MAP1B ARHGAP44 EIF4G1 PRICKLE2 NBEA DGCR8 SLC1A1 DICER1 CHRNB4	1.83e-03	1018	93	12	GO:0098794
HumanPheno	Abnormal thought pattern	ZNF526 DRD2 CLCN3 IMPDH2 MAP1B KAT6A KMT2A DGCR8 HERC2 GTF2IRD1 RAD21	9.35e-06	404	30	11	HP:5200269
HumanPheno	Restricted or repetitive behaviors or interests	ZNF526 DRD2 CLCN3 IMPDH2 MAP1B KAT6A KMT2A HERC2 GTF2IRD1 RAD21	2.78e-05	368	30	10	HP:0031432
HumanPheno	Perseverative thought	ZNF526 DRD2 CLCN3 IMPDH2 MAP1B KAT6A KMT2A HERC2 GTF2IRD1 RAD21	3.43e-05	377	30	10	HP:0030223
HumanPheno	Disordered formal thought process	ZNF526 DRD2 CLCN3 IMPDH2 MAP1B KAT6A KMT2A HERC2 GTF2IRD1 RAD21	4.21e-05	386	30	10	HP:0025769
HumanPheno	Broad lateral eyebrow	KMT2A SON	1.00e-04	3	30	2	HP:0007933
MousePheno	reduced fertility	FREM2 DRD2 LIPE CLCN3 MAP1B TRPC5 KAT6A KMT2A AKAP13 SMARCAD1 HERC2 HSF2 ANKH ZFX VDR RAD21	1.14e-05	844	77	16	MP:0001921
MousePheno	reduced female fertility	DRD2 TRPC5 KMT2A SMARCAD1 HERC2 HSF2 ANKH ZFX VDR	3.46e-05	296	77	9	MP:0001923
MousePheno	decreased spleen weight	DRD2 SLC14A1 KAT6A EIF4G1 AKAP13 DICER1	3.63e-05	113	77	6	MP:0004953
MousePheno	abnormal response to novelty	SLC12A6 DRD2 SHANK2 CLCN3 MAP1B ARHGAP44 EIF4G1 GTF2IRD1 SLC1A1 ATP10A DSCAML1 AREG SON VDR	8.75e-05	787	77	14	MP:0003107
MousePheno	short face	FREM2 KMT2A HCFC1	1.03e-04	17	77	3	MP:0030066
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	AKAP6 FREM2 NRXN3 SHANK2 PHF20 MAP1B KMT2A SHISA2 SMARCAD1 HERC2 NEB HSF2 CBL DICER1 DSCAML1 HCFC1 ZFX	1.04e-04	1124	77	17	MP:0011112
MousePheno	abnormal seizure response to pharmacological agent	SLC12A6 DRD2 CLCN3 TRPC5 PRICKLE2 CHRNB4	1.57e-04	147	77	6	MP:0000950
Domain	DS_RBD	DGCR8 DICER1 SON	1.31e-04	21	89	3	PS50137
Domain	-	DGCR8 DICER1 SON	2.82e-04	27	89	3	3.30.160.20
Domain	AT_hook	PHF20 KMT2A BOD1L1	2.82e-04	27	89	3	SM00384
Domain	AT_hook_DNA-bd_motif	PHF20 KMT2A BOD1L1	2.82e-04	27	89	3	IPR017956
Domain	dsRBD_dom	DGCR8 DICER1 SON	3.14e-04	28	89	3	IPR014720
Domain	ENTH_VHS	U2SURP RPRD2 EPN2	3.49e-04	29	89	3	IPR008942
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	PHF20 KMT2A BOD1L1 HCFC1	4.76e-05	38	75	4	MM17073
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	PHF20 KMT2A BOD1L1 HCFC1	7.10e-05	42	75	4	M48018
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC4 MUC20	7.71e-05	16	75	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC4 MUC20	9.32e-05	17	75	3	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC4 MUC20	1.80e-04	21	75	3	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC4 MUC20	2.37e-04	23	75	3	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC4 MUC20	3.44e-04	26	75	3	M27483
Pathway	WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS	DGCR8 DICER1	4.13e-04	6	75	2	M39578
Pathway	WP_MIRNA_BIOGENESIS	DGCR8 DICER1	4.13e-04	6	75	2	M39416
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4 MUC20	1.85e-08	3	93	3	30236127
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IMPDH2 MAP1B U2SURP EIF4G1 MKI67 BYSL KMT2A HERC2 DICER1 HCFC1 PPP6R3 SON RAD21	2.10e-08	653	93	13	22586326
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FREM2 ARHGEF28 CLCN3 RPAP1 IMPDH2 MAP1B KMT2A AKAP13 SMARCAD1 DICER1 HCFC1 RBM20	1.72e-07	650	93	12	38777146
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MRPS31 SHANK2 IMPDH2 PIEZO1 SUPT7L EIF4G1 BYSL KMT2A ZNF217 DGCR8 ITPRID2 HERC2 DICER1 EPN2 PPP6R3 SON RAD21	4.23e-07	1497	93	17	31527615
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	TOX4 IMPDH2 MAP1B KAT6A EIF4G1 MKI67 BYSL DGCR8 HERC2 HSF2 SON RAD21	8.87e-07	759	93	12	35915203
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TOX4 IMPDH2 MAP1B U2SURP MKI67 KMT2A RPRD2 AASDHPPT BOD1L1 HCFC1 PPP6R3 SON RAD21	1.24e-06	934	93	13	33916271
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TOX4 MAP1B U2SURP EIF4G1 MKI67 BYSL KMT2A RPRD2 BOD1L1 DGCR8 HCFC1 SON RAD21	1.57e-06	954	93	13	36373674
Pubmed	Crosstalk between NSL histone acetyltransferase and MLL/SET complexes: NSL complex functions in promoting histone H3K4 di-methylation activity by MLL/SET complexes.	PHF20 KMT2A HCFC1	2.19e-06	10	93	3	24244196
Pubmed	Human transcription factor protein interaction networks.	MRPS31 IMPDH2 SUPT7L EIF4G1 MKI67 KMT2A RPRD2 ZNF217 HERC2 CABIN1 HCFC1 RBM20 ZNF691 PPP6R3 RAD21	5.73e-06	1429	93	15	35140242
Pubmed	MicroRNA activity is suppressed in mouse oocytes.	DGCR8 DICER1	7.07e-06	2	93	2	20116252
Pubmed	Thin filament length in the cardiac sarcomere varies with sarcomere length but is independent of titin and nebulin.	NEB RBM20	7.07e-06	2	93	2	27139341
Pubmed	MicroRNA-processing Enzymes Are Essential for Survival and Function of Mature Retinal Pigmented Epithelial Cells in Mice.	DGCR8 DICER1	7.07e-06	2	93	2	28104803
Pubmed	Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models.	DRD2 DGCR8	7.07e-06	2	93	2	24904170
Pubmed	Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.	DGCR8 DICER1	7.07e-06	2	93	2	38252873
Pubmed	Skeletal stem and progenitor cells maintain cranial suture patency and prevent craniosynostosis.	AXIN2 TWIST1	7.07e-06	2	93	2	34330896
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	7.07e-06	2	93	2	23544943
Pubmed	Germ cell-specific targeting of DICER or DGCR8 reveals a novel role for endo-siRNAs in the progression of mammalian spermatogenesis and male fertility.	DGCR8 DICER1	7.07e-06	2	93	2	25244517
Pubmed	A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing.	DGCR8 DICER1	7.07e-06	2	93	2	21712401
Pubmed	CBL mutations in infant acute lymphoblastic leukaemia.	KMT2A CBL	7.07e-06	2	93	2	21988239
Pubmed	DGCR8-dependent microRNA biogenesis is essential for skin development.	DGCR8 DICER1	7.07e-06	2	93	2	19114655
Pubmed	Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.	KMT2A CBL	7.07e-06	2	93	2	12696071
Pubmed	Dgcr8 and Dicer are essential for sex chromosome integrity during meiosis in males.	DGCR8 DICER1	7.07e-06	2	93	2	25934699
Pubmed	Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation.	CBL TWIST1	7.07e-06	2	93	2	17003487
Pubmed	A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes.	DGCR8 DICER1	7.07e-06	2	93	2	24209619
Pubmed	Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.	MUC4 MUC20	7.07e-06	2	93	2	26673820
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RPAP1 EIF4G1 MKI67 KMT2A ZNF217 SMARCAD1 ITPRID2 GTF2IRD1 ZFX PPP6R3 SON	7.19e-06	774	93	11	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RIN3 SHANK2 RPAP1 PIEZO1 ARHGAP44 KAT6A EIF4G1 AKAP13 HERC2 GTF2IRD1 CABIN1 FAAP100 HCFC1	7.74e-06	1105	93	13	35748872
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 U2SURP PPIP5K1 HERC2 CABIN1	9.15e-06	104	93	5	9205841
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TOX4 PHF20 KCTD10 U2SURP EIF4G1 MKI67 C11orf24 HERC2 HSF2 FAAP100 HCFC1 PRRC1 RAD21	1.24e-05	1155	93	13	20360068
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC4 MUC20	1.47e-05	18	93	3	18834073
Pubmed	VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland.	MKI67 PRICKLE2 AXIN2	1.47e-05	18	93	3	31068622
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	IMPDH2 EIF4G1 AKAP13 ITPRID2 HERC2 DICER1	1.78e-05	202	93	6	33005030
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TOX4 MKI67 KMT2A ZNF217 GTF2IRD1 CBL PRDM4 ZFX TWIST1 VDR	2.05e-05	709	93	10	22988430
Pubmed	Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis.	AXIN2 TWIST1	2.12e-05	3	93	2	20547147
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	2.12e-05	3	93	2	23053434
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MKI67 MUC16	2.12e-05	3	93	2	27163153
Pubmed	A microRNA expression signature of osteoclastogenesis.	DGCR8 DICER1	2.12e-05	3	93	2	21273303
Pubmed	SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.	KMT2A SON	2.12e-05	3	93	2	26990989
Pubmed	E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.	KMT2A HCFC1	2.12e-05	3	93	2	19763085
Pubmed	Overexpression of TrpC5 promotes tumor metastasis via the HIF-1α-Twist signaling pathway in colon cancer.	TRPC5 TWIST1	2.12e-05	3	93	2	28864720
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC20	2.12e-05	3	93	2	26770020
Pubmed	Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8.	DGCR8 DICER1	2.12e-05	3	93	2	32124011
Pubmed	Drosha, DGCR8, and Dicer mRNAs are down-regulated in human cells infected with dengue virus 4, and play a role in viral pathogenesis.	DGCR8 DICER1	2.12e-05	3	93	2	27173348
Pubmed	EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.	CBL AREG	2.12e-05	3	93	2	18045238
Pubmed	Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models.	CNTN4 SHANK2	2.12e-05	3	93	2	29970989
Pubmed	Non-canonical microRNAs miR-320 and miR-702 promote proliferation in Dgcr8-deficient embryonic stem cells.	DGCR8 DICER1	2.12e-05	3	93	2	22925886
Pubmed	Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.	DICER1 ALOX12	2.12e-05	3	93	2	15576842
Pubmed	Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcoma.	MKI67 VDR	2.12e-05	3	93	2	22542077
Pubmed	Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.	DGCR8 DICER1	2.12e-05	3	93	2	23663110
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	2.12e-05	3	93	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	2.12e-05	3	93	2	24204560
Pubmed	The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection.	KMT2A HCFC1	2.12e-05	3	93	2	17578910
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	2.12e-05	3	93	2	24939955
Pubmed	Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.	DGCR8 DICER1	2.12e-05	3	93	2	25439752
Pubmed	The miRNA biogenesis pathway prevents inappropriate expression of injury response genes in developing and adult Schwann cells.	DGCR8 DICER1	2.12e-05	3	93	2	30295958
Pubmed	Y chromosomal noncoding RNAs regulate autosomal gene expression via piRNAs in mouse testis.	PMEL CABIN1	2.12e-05	3	93	2	34503492
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	2.12e-05	3	93	2	17592322
Pubmed	A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus.	MUC4 MUC20	2.12e-05	3	93	2	35065708
Pubmed	Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy.	NEB RBM20	2.12e-05	3	93	2	27889803
Pubmed	MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.	KAT6A MKI67	2.12e-05	3	93	2	24307508
Pubmed	Biogenesis of mammalian microRNAs by a non-canonical processing pathway.	DGCR8 DICER1	2.12e-05	3	93	2	22270084
Pubmed	Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.	KMT2A MUC4	2.12e-05	3	93	2	31592798
Pubmed	Set1/MLL complex is indispensable for the transcriptional ability of heat shock transcription factor 2.	KMT2A HSF2	2.12e-05	3	93	2	26478434
Pubmed	Craniosynostosis of coronal suture in twist1 mice occurs through endochondral ossification recapitulating the physiological closure of posterior frontal suture.	AXIN2 TWIST1	2.12e-05	3	93	2	21811467
Pubmed	Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters.	DRD2 KMT2A	2.12e-05	3	93	2	17942719
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	2.12e-05	3	93	2	35879412
Pubmed	Transcript Level of MicroRNA Processing Elements in Gastric Cancer.	DGCR8 DICER1	2.12e-05	3	93	2	30168106
Pubmed	Piezo1 agonist restores meningeal lymphatic vessels, drainage, and brain-CSF perfusion in craniosynostosis and aged mice.	PIEZO1 TWIST1	2.12e-05	3	93	2	37917195
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	MAP1B U2SURP MKI67 RPRD2 SON	2.70e-05	130	93	5	35545047
Pubmed	Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis.	MKI67 DICER1 AXIN2	2.75e-05	22	93	3	25651362
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2A BOD1L1 HCFC1	2.75e-05	22	93	3	26886794
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MRPS31 FREM2 RPAP1 PRICKLE2 C11orf24 AKAP13 NBEA BOD1L1 DSCAML1 CHRNB4	2.82e-05	736	93	10	29676528
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	IMPDH2 RPRD2 BOD1L1 DGCR8 SAGE1 GTF2IRD1 CABIN1 FAAP100	3.02e-05	453	93	8	29656893
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	MRPS31 BYSL AASDHPPT CBL DICER1 PPP6R3	3.11e-05	223	93	6	33187986
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	U2SURP SUPT7L KMT2A RPRD2 HCFC1	3.12e-05	134	93	5	25452129
Pubmed	Tagging genes with cassette-exchange sites.	KCTD10 EIF4G1 MKI67 AKAP13 SMARCAD1 DGCR8 PPP6R3	3.37e-05	335	93	7	15741177
Pubmed	Anti-osteogenic function of a LIM-homeodomain transcription factor LMX1B is essential to early patterning of the calvaria.	MKI67 AXIN2 TWIST1	3.60e-05	24	93	3	29852132
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KAT6A MKI67 KMT2A BOD1L1 SMARCAD1 HERC2 CABIN1 HCFC1 RAD21	3.75e-05	608	93	9	36089195
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TOX4 PHF20 U2SURP SUPT7L MKI67 KMT2A RPRD2 GTF2IRD1 CABIN1 HCFC1 ZFX SON RAD21	4.04e-05	1294	93	13	30804502
Pubmed	The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.	EIF4G1 KMT2A HERC2 RAD21	4.06e-05	71	93	4	29346117
Pubmed	MicroRNAs are essential for differentiation of the retinal pigmented epithelium and maturation of adjacent photoreceptors.	MKI67 DGCR8 DICER1	4.08e-05	25	93	3	26062936
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC12A6 SHANK2 PDE9A MAP1B ARHGAP44 KAT6A RASGEF1C AKAP13 RPRD2 BOD1L1 GTF2IRD1 SLC1A1 ATP10A ANKH	4.09e-05	1489	93	14	28611215
Pubmed	Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface.	DRD2 TRPC5	4.23e-05	4	93	2	18261457
Pubmed	Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.	MKI67 VDR	4.23e-05	4	93	2	12174912
Pubmed	DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epithelium.	MKI67 PMEL	4.23e-05	4	93	2	28334846
Pubmed	The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13.	C11orf24 PPP6R3	4.23e-05	4	93	2	11401438
Pubmed	MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development.	MKI67 DICER1	4.23e-05	4	93	2	21969379
Pubmed	Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing Cells of the Developing and Malignant Cerebellum.	DGCR8 DICER1	4.23e-05	4	93	2	26748703
Pubmed	Distinct requirements of microRNAs in NK cell activation, survival, and function.	DGCR8 DICER1	4.23e-05	4	93	2	20805417
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	4.23e-05	4	93	2	39024979
Pubmed	Adipose Tissue Macrophages Modulate Obesity-Associated β Cell Adaptations through Secreted miRNA-Containing Extracellular Vesicles.	MKI67 DICER1	4.23e-05	4	93	2	34572101
Pubmed	Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.	KAT6A KMT2A	4.23e-05	4	93	2	23994619
Pubmed	Recognition of unknown conserved alternatively spliced exons.	PPIP5K1 SON	4.23e-05	4	93	2	16110330
Pubmed	TNFAIP1 interacts with KCTD10 to promote the degradation of KCTD10 proteins and inhibit the transcriptional activities of NF-κB and AP-1.	RIN3 KCTD10	4.23e-05	4	93	2	22810651
Pubmed	Distinct roles of microRNAs in epithelium and mesenchyme during tooth development.	MKI67 DICER1 AXIN2	4.60e-05	26	93	3	22753148
Pubmed	A protein interaction landscape of breast cancer.	TOX4 IMPDH2 MKI67 RO60 SMARCAD1 ITPRID2 AREG PPP6R3 RAD21	5.18e-05	634	93	9	34591612
Pubmed	Modeling digits. Digit patterning is controlled by a Bmp-Sox9-Wnt Turing network modulated by morphogen gradients.	SHISA2 AXIN2 TWIST1	5.78e-05	28	93	3	25082703
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EIF4G1 MKI67 AKAP13 RPRD2 CBL HCFC1 PPP6R3 SON	6.29e-05	503	93	8	16964243
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MRPS31 IMPDH2 U2SURP MKI67 BYSL BOD1L1 ZNF217 DGCR8 HCFC1 SON RAD21	6.77e-05	989	93	11	36424410
Pubmed	Piezo1 regulates the regenerative capacity of skeletal muscles via orchestration of stem cell morphological states.	PIEZO1 MKI67	7.04e-05	5	93	2	35302846
Interaction	ARRDC2 interactions	MAP1B BOD1L1 HCFC1 EPN2 PPP6R3	4.46e-06	54	91	5	int:ARRDC2
Cytoband	11q23	DRD2 KMT2A DSCAML1	5.47e-05	36	93	3	11q23
Cytoband	15q13	SLC12A6 HERC2	1.45e-04	9	93	2	15q13
GeneFamily	CD molecules\|Mucins	MUC16 MUC22 MUC4 MUC20	5.48e-07	21	58	4	648
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 AKAP13 NBEA	1.08e-04	29	58	3	396
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAP1B TRPC5 MKI67 HCFC1 VDR	2.84e-04	181	58	5	694
GeneFamily	PHD finger proteins	PHF20 KAT6A KMT2A	3.02e-03	90	58	3	88
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRXN3 SHANK2 MUC16 NBEA MUC4 MUC20	1.13e-06	161	93	6	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	NRXN3 ARHGEF28 SHANK2 MUC16 NBEA MUC4	2.37e-06	183	93	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHANK2 PDE9A PIEZO1 RASGEF1C MUC4 MUC20	2.86e-06	189	93	6	27e5d706f10a6221f314faf642eede15deab3165
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	NRXN3 ARHGEF28 SHANK2 MUC16 NBEA MUC4	2.94e-06	190	93	6	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 MUC16 NBEA MUC4 NEK11 CDHR4	3.32e-06	194	93	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B KMT2A NBEA BOD1L1 SON VDR	3.42e-06	195	93	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B KMT2A NBEA BOD1L1 SON VDR	3.42e-06	195	93	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.52e-06	196	93	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.73e-06	198	93	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.73e-06	198	93	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.73e-06	198	93	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.73e-06	198	93	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CNTN4 NRXN3 SHANK2 MAP1B ARHGAP44 NBEA	3.96e-06	200	93	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	KMT2A AKAP13 BOD1L1 AREG SON RAD21	3.96e-06	200	93	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LIPE NRXN3 ARHGEF28 SHANK2 ARHGAP44	8.83e-06	133	93	5	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPIP5K1 NBEA AASDHPPT HSF2 CHRNB4	2.43e-05	164	93	5	d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8
ToppCell	Control\|World / group, cell type (main and fine annotations)	CNTN4 FREM2 NRXN3 ARHGEF28 SHANK2	2.73e-05	168	93	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	facs-Lung-EPCAM-3m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 NEB SLC1A1 ATP10A VDR	2.88e-05	170	93	5	82ccba6ec53f6ca0d19949a1277434c565af2983
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 NEB SLC1A1 ATP10A VDR	2.88e-05	170	93	5	ab19ea729ed8c8361c870e79893d1a95a1e487fa
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRXN3 CLCN3 PDE9A AKAP13 ITPRID2	2.97e-05	171	93	5	0de81d12a8000f2c59cdb214e67dc526d18098fe
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRXN3 CLCN3 PDE9A AKAP13 ITPRID2	2.97e-05	171	93	5	0597339618fb4d416d55c538eceb353218a55002
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	MAP1B MUC16 NBEA NEK11 CDHR4	3.05e-05	172	93	5	187ae91148d293537afc77e10da2b64302322224
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGEF1C PPIP5K1 SHISA2 ZNF691 VDR	3.22e-05	174	93	5	6987fe7959afce347282f632abc16d800ccab7c4
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ARHGEF28 SHANK2 DSCAML1 ZFX ZNF710	3.40e-05	176	93	5	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTN4 FREM2 SHANK2 ARHGAP44 SLC1A1	3.69e-05	179	93	5	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DRD2 MAP1B NBEA ITPRID2 ADGRG4	3.69e-05	179	93	5	8ce5000088b727783a0619baa16a2cd036d21f54
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTN4 ARHGEF28 SHANK2 SLC1A1 DSCAML1	3.79e-05	180	93	5	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTN4 ARHGEF28 SHANK2 SLC1A1 DSCAML1	3.79e-05	180	93	5	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRXN3 SHANK2 MUC16 NBEA MUC4	3.99e-05	182	93	5	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTN4 ARHGEF28 SHANK2 SLC1A1 DSCAML1	4.10e-05	183	93	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM2 NRXN3 ARHGEF28 SHANK2 ARHGAP44	4.32e-05	185	93	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CNTN4 NRXN3 SHANK2 ARHGAP44 MUC4	4.32e-05	185	93	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AKAP6 SHANK2 MAP1B NEK11 CDHR4	4.32e-05	185	93	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 NRXN3 MAP1B ATP10A RBM20	4.54e-05	187	93	5	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTN4 SHANK2 ARHGAP44 GTF2IRD1 SLC1A1	4.54e-05	187	93	5	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 NRXN3 MAP1B ATP10A RBM20	4.54e-05	187	93	5	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHANK2 ARHGAP44 GTF2IRD1 MUC4 AREG	4.66e-05	188	93	5	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CNTN4 ARHGEF28 SHANK2 NBEA MUC4	4.78e-05	189	93	5	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	AKAP6 AKAP13 GTF2IRD1 ANKH RBM20	4.90e-05	190	93	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 NRXN3 ARHGEF28 SHANK2 AREG	4.90e-05	190	93	5	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GARIN4 ARHGAP44 SHISA2 ITPRID2 VDR	5.02e-05	191	93	5	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CNTN4 FREM2 SHANK2 ARHGAP44 SLC1A1	5.02e-05	191	93	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 NRXN3 ARHGEF28 SHANK2 AREG	5.15e-05	192	93	5	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	ASK452-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	CLCN3 PHF20 AKAP13 AREG RAD21	5.15e-05	192	93	5	8269b88ff6073a908f547fcc7c5941f2e8289694
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 NRXN3 MAP1B ATP10A RBM20	5.15e-05	192	93	5	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	PIEZO1 MKI67 KMT2A BOD1L1 SON	5.15e-05	192	93	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FREM2 SHANK2 ARHGAP44 AKAP13 SLC1A1	5.15e-05	192	93	5	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 NRXN3 ARHGEF28 SHANK2 AREG	5.15e-05	192	93	5	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 NRXN3 ARHGEF28 SHANK2 AREG	5.15e-05	192	93	5	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CNTN4 NRXN3 SHANK2 NBEA MUC4	5.28e-05	193	93	5	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCN3 PDE9A RASGEF1C MUC4 MUC20	5.28e-05	193	93	5	1526f51b589a7dc7a28f35f0e788dc38d338d2bc
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A RASGEF1C MUC4 MUC20 VDR	5.41e-05	194	93	5	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCN3 PDE9A SLC1A1 MUC4 MUC20	5.41e-05	194	93	5	550e61a40be2baa59520aaf5912bb99ad094ba15
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	RPAP1 PIEZO1 ITPRID2 ATP10A EPN2	5.41e-05	194	93	5	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	RPAP1 PIEZO1 ITPRID2 ATP10A EPN2	5.41e-05	194	93	5	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SHANK2 PRICKLE2 SLC1A1 MUC4 CDHR4	5.54e-05	195	93	5	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRPS31 MUC16 NBEA NEK11 CDHR4	5.54e-05	195	93	5	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	facs-Skin-nan-18m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GARIN4 SLC14A1 ARHGAP44 SHISA2 ANKH	5.68e-05	196	93	5	81f9754567bbfa67edd304b9ef7b03e7bd9a3b52
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRPS31 MUC16 NBEA AXIN2 TWIST1	5.68e-05	196	93	5	d9426eba69047166ffa8179f1654e011c1020328
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	SHANK2 MKI67 PRICKLE2 MUC4 CDHR4	5.68e-05	196	93	5	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRPS31 MUC16 NBEA AXIN2 TWIST1	5.68e-05	196	93	5	7e19919eafd6ddf547dd4e8aa532a050e182c5cc
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	SHANK2 MKI67 PRICKLE2 MUC4 CDHR4	5.68e-05	196	93	5	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM2 ARHGEF28 SHANK2 PDE9A GTF2IRD1	5.68e-05	196	93	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	droplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A PIEZO1 RASGEF1C MUC4 MUC20	5.82e-05	197	93	5	ed3a37f532741764060d297a560eeeeec279d9c4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPC5 ICAM3 SIGLEC5 AREG VDR	5.82e-05	197	93	5	ad4147435ac0fdf6274fea6d535f4e00d990e535
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGEF28 MUC16 NBEA MUC4 MUC20	5.96e-05	198	93	5	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGEF28 MUC16 NBEA MUC4 MUC20	5.96e-05	198	93	5	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRXN3 SHANK2 MUC16 NBEA MUC4	5.96e-05	198	93	5	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRXN3 ARHGEF28 MUC16 NBEA MUC4	6.25e-05	200	93	5	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	BAL-Control-cDC_7\|Control / Compartment, Disease Groups and Clusters	SUPT7L SLC9B2 ATP10A AREG	1.21e-04	121	93	4	b49b044a687a31883dfccecf10a183b5ba567f7a
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRXN3 SHANK2 ARHGAP44 AKAP13	1.46e-04	127	93	4	5b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCell	(06)_Krt4/13+-(4)_1wkpi\|(06)_Krt4/13+ / shred by cell type and Timepoint	SLC1A1 MUC20	1.88e-04	10	93	2	c76279ff80347dfffb7d7074b37085e53d047509
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ZNF526 SLC14A1 PMEL BRSK1	2.00e-04	138	93	4	05de2cef97c0912fb23f138dd45348f565a14d74
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CNTN4 TRPC5 RASGEF1C DSCAML1	2.68e-04	149	93	4	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF28 PIEZO1 ATP10A MUC20	2.89e-04	152	93	4	7a1072315cce71eefe2d32149a107d5648999968
ToppCell	PND01-03-samps-Myeloid-Macrophage-macrophage-B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MKI67 SIGLEC5 ATP10A NEK11	2.89e-04	152	93	4	5ce8920aedd39a4daf7082153b5e213707c14227
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	NRXN3 SHANK2 MUC16 BRSK1	2.97e-04	153	93	4	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	Severe-B_naive-5\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MAP1B SHISA2 NEK11 AXIN2	2.97e-04	153	93	4	44572f87d403e314050ab935d2cd676c33d9c287
ToppCell	RV-16._Neuronal\|RV / Chamber and Cluster_Paper	NRXN3 PDE9A MAP1B RASGEF1C	2.97e-04	153	93	4	bed8bbf5c5cbfbf46a816066da472c3fdddecb5d
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF28 PIEZO1 ATP10A MUC20	3.04e-04	154	93	4	6c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCell	Severe-B_naive-5\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MAP1B SHISA2 NEK11 AXIN2	3.27e-04	157	93	4	a57ee4a6febdff3ee3d1645836695e6e7c055cf8
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP44 EIF4G1 GTF2IRD1 AXIN2	3.52e-04	160	93	4	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	MAP1B BRSK1 HCFC1 RBM20	3.60e-04	161	93	4	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKAP6 SLC14A1 RASGEF1C AREG	3.77e-04	163	93	4	360cd65decda24853124f33a174f5224d7f3ce23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKAP6 SLC14A1 RASGEF1C AREG	3.77e-04	163	93	4	b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 MAP1B ATP10A TWIST1	3.95e-04	165	93	4	4f83ac71efc57be3668d8db1e62bad05dc6a5e2b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 MAP1B ATP10A TWIST1	3.95e-04	165	93	4	cd8de98af8a1a8a6c81d71fae807cc07f319f4c9
ToppCell	3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 ZNF526 KAT6A FAAP100	4.04e-04	166	93	4	b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RIN3 SLC14A1 SIGLEC5 ANKH	4.13e-04	167	93	4	fd84a99ea142d1684cdcf4a88ef1d541760bc78a
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTN4 ARHGEF28 SHANK2 DSCAML1	4.23e-04	168	93	4	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEMP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	IMPDH2 ALOX12 NEK11 MUC20	4.32e-04	169	93	4	9a2fedee8ff90513bc2cbe2a65d07575ee8a0b70
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 NBEA NEK11 CDHR4	4.32e-04	169	93	4	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTN4 SHANK2 PRICKLE2 RSPH6A	4.42e-04	170	93	4	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SLC14A1 PPIP5K1 ATP10A NEK11	4.42e-04	170	93	4	c1f7f1bb8865e954bb499963d82bb51923d5d8d6
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM2 MUC16 MUC4 MUC20	4.52e-04	171	93	4	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM2 MUC16 MUC4 MUC20	4.52e-04	171	93	4	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	facs-GAT-Fat-24m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A MUC4 CHRNB4 VDR	4.72e-04	173	93	4	815ba48a9222ea09ba8005e2d2f7c5addf118ad1
ToppCell	facs-GAT-Fat-24m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A MUC4 CHRNB4 VDR	4.72e-04	173	93	4	98e464d9e6d6b69421e9e4041b638b6825247f60
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRXN3 MUC16 NBEA MUC4	4.72e-04	173	93	4	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	facs-GAT-Fat-24m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A MUC4 CHRNB4 VDR	4.72e-04	173	93	4	3e6f0a08eddfd61871f7a85acccf6d539af6ebda
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A	LIPE CLCN3 MAP1B TRPC5 KAT6A DGCR8 ANKH DICER1	1.47e-06	199	92	8	4334_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARHGEF28 MKI67 GTF2IRD1 DICER1 HCFC1 ZFX RAD21	6.84e-06	174	92	7	5940_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	PHF20 EIF4G1 KMT2A AKAP13 RO60 DICER1 SON	7.66e-06	177	92	7	985_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	EIF4G1 KMT2A AKAP13 RO60 DICER1 SON RAD21	7.94e-06	178	92	7	3998_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	TOX4 EIF4G1 KMT2A RO60 DICER1 SON RAD21	1.13e-05	188	92	7	6735_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	CLCN3 MAP1B KAT6A AKAP13 NEB CBL DICER1	1.26e-05	191	92	7	4279_DN
Drug	Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RIN3 KMT2A DGCR8 NEB CBL ZFX ZNF710	1.49e-05	196	92	7	2780_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A	DRD2 POM121L2 RO60 DGCR8 GTF2IRD1 EPN2 VDR	1.49e-05	196	92	7	2158_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	SLC12A6 RIN3 PHF20 RPAP1 KAT6A HCFC1 VDR	1.54e-05	197	92	7	4355_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	DRD2 NBEA NEB GTF2IRD1 HCFC1 ALOX12 EPN2	1.54e-05	197	92	7	2702_DN
Drug	Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A	SLC12A6 SHANK2 U2SURP C11orf24 AKAP13 FAAP100 ZNF710	1.59e-05	198	92	7	6302_DN
Drug	CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A	PDE9A U2SURP RO60 HSF2 NEK11 ZFX ZNF710	1.59e-05	198	92	7	7532_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DRD2 MAP1B KMT2A NEB CABIN1 ZNF710 VDR	1.64e-05	199	92	7	6092_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A	ICAM3 KMT2A AKAP13 RPRD2 DGCR8 CABIN1 ZNF710	1.69e-05	200	92	7	1592_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SLC14A1 U2SURP RPRD2 GTF2IRD1 HCFC1 ZFX	5.27e-05	163	92	6	7285_DN
Drug	HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	RO60 DGCR8 GTF2IRD1 HCFC1 ZFX ZNF710	7.57e-05	174	92	6	909_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	EIF4G1 KMT2A RO60 DICER1 SON RAD21	8.85e-05	179	92	6	4585_DN
Drug	sulfolene	TWIST1 VDR	9.64e-05	4	92	2	CID000006498
Drug	Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	TOX4 CLCN3 HSF2 DICER1 PRRC1 RAD21	1.03e-04	184	92	6	1344_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	DRD2 PHF20 RO60 DGCR8 NEB VDR	1.30e-04	192	92	6	6809_DN
Drug	geldanamycin	MAP1B KAT6A KMT2A BOD1L1 RO60 ITPRID2 CBL ZFX	1.30e-04	371	92	8	ctd:C001277
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A	U2SURP SUPT7L C11orf24 AKAP13 ITPRID2 DICER1	1.34e-04	193	92	6	6205_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RIN3 DRD2 KAT6A RO60 HCFC1 VDR	1.38e-04	194	92	6	4149_DN
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	TOX4 TRPC5 DGCR8 ATP10A HCFC1 ALOX12	1.38e-04	194	92	6	6380_DN
Drug	Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	DRD2 MAP1B TRPC5 KAT6A NEB ZNF710	1.38e-04	194	92	6	7032_UP
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	RPAP1 PIEZO1 C11orf24 CABIN1 HCFC1 ZFX	1.38e-04	194	92	6	1179_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A	U2SURP C11orf24 HSF2 HCFC1 EPN2 VDR	1.41e-04	195	92	6	7435_UP
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; HL60; HG-U133A	KMT2A C11orf24 ZNF217 DGCR8 ATP10A SON	1.41e-04	195	92	6	2006_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A	ARHGEF28 TRPC5 KAT6A POM121L2 ALOX12 VDR	1.41e-04	195	92	6	2245_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	RIN3 RPAP1 U2SURP BYSL DGCR8 VDR	1.41e-04	195	92	6	1207_DN
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	U2SURP AASDHPPT RO60 HSF2 ZFX EPN2	1.41e-04	195	92	6	5305_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A	RIN3 PHF20 RPAP1 RO60 ZFX ZNF710	1.41e-04	195	92	6	3108_DN
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; HL60; HG-U133A	ICAM3 CBL ATP10A PRRC1 ZFX ZNF710	1.41e-04	195	92	6	1619_UP
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	DRD2 PHF20 KAT6A AKAP13 FAAP100 EPN2	1.41e-04	195	92	6	4106_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	PHF20 RPAP1 MAP1B SUPT7L DGCR8 VDR	1.41e-04	195	92	6	6828_DN
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	SLC12A6 RPAP1 RO60 HSF2 NEK11 ZFX	1.45e-04	196	92	6	4392_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CLCN3 PHF20 MAP1B KMT2A AKAP13 HCFC1	1.45e-04	196	92	6	2775_DN
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	RIN3 DRD2 SHANK2 MAP1B AKAP13 DGCR8	1.45e-04	196	92	6	6571_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	RIN3 POM121L2 ATP10A ANKH DICER1 ZNF710	1.45e-04	196	92	6	6824_UP
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	RPAP1 AKAP13 RPRD2 PMEL EPN2 VDR	1.45e-04	196	92	6	4718_DN
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A	AKAP13 RO60 DGCR8 GTF2IRD1 HCFC1 ZNF710	1.45e-04	196	92	6	2736_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	MAP1B RO60 PMEL NEB HCFC1 ZNF710	1.45e-04	196	92	6	5343_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A	PHF20 KAT6A NEB DICER1 ZFX ZNF710	1.45e-04	196	92	6	4987_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A	POM121L2 AKAP13 CABIN1 CBL HCFC1 ZNF710	1.50e-04	197	92	6	7014_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	RIN3 DRD2 POM121L2 NEB FAAP100 HCFC1	1.50e-04	197	92	6	4318_DN
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	RIN3 NEB FAAP100 ATP10A HCFC1 NEK11	1.50e-04	197	92	6	7401_UP
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A	LIPE NRXN3 SHANK2 SIGLEC5 ALOX12 VDR	1.50e-04	197	92	6	4305_UP
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	AKAP6 PHF20 MAP1B SUPT7L CABIN1 HCFC1	1.50e-04	197	92	6	2809_UP
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A	U2SURP DGCR8 HSF2 CBL ATP10A EPN2	1.50e-04	197	92	6	1750_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	MAP1B KAT6A AKAP13 CABIN1 FAAP100 ZNF710	1.50e-04	197	92	6	7440_DN
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	DRD2 NRXN3 POM121L2 PMEL CBL ATP10A	1.50e-04	197	92	6	4766_UP
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	NRXN3 MAP1B SLC14A1 AKAP13 DGCR8 CABIN1	1.50e-04	197	92	6	7262_UP
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	DRD2 AKAP13 RO60 CABIN1 HCFC1 NEK11	1.50e-04	197	92	6	7194_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	RPAP1 KMT2A AKAP13 RO60 HCFC1 EPN2	1.50e-04	197	92	6	3406_DN
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; PC3; HT_HG-U133A	DRD2 U2SURP ARHGAP44 AKAP13 NEB NEK11	1.50e-04	197	92	6	4506_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	DRD2 PDE9A SLC14A1 NEB ANKH ALOX12	1.54e-04	198	92	6	3215_UP
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A	NRXN3 ARHGEF28 SUPT7L KAT6A HSF2 ZFX	1.54e-04	198	92	6	6557_DN
Drug	prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	DRD2 MAP1B NEB ATP10A NEK11 EPN2	1.54e-04	198	92	6	6590_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	SHANK2 RPRD2 CBL NEK11 ZNF710 VDR	1.54e-04	198	92	6	6790_DN
Drug	Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	PHF20 POM121L2 CBL ATP10A NEK11 ZFX	1.54e-04	198	92	6	7437_UP
Drug	(1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A	DRD2 AKAP13 CABIN1 CBL HCFC1 ZNF710	1.54e-04	198	92	6	7296_UP
Drug	Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A	RPRD2 CABIN1 PRDM4 ATP10A DICER1 RAD21	1.54e-04	198	92	6	1560_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DRD2 CLCN3 C11orf24 DGCR8 PRDM4 HCFC1	1.54e-04	198	92	6	7177_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A	DRD2 PHF20 KAT6A AKAP13 NEB ANKH	1.54e-04	198	92	6	4464_DN
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; HL60; HG-U133A	AKAP6 RPAP1 DGCR8 PRDM4 FAAP100 ZNF710	1.54e-04	198	92	6	1762_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	AKAP6 MAP1B KAT6A DGCR8 ATP10A ANKH	1.54e-04	198	92	6	4343_UP
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	C11orf24 AKAP13 NEB HSF2 HCFC1 EPN2	1.54e-04	198	92	6	5286_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	SHANK2 RO60 CBL ANKH HCFC1 VDR	1.54e-04	198	92	6	3854_DN
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A	RIN3 SIGLEC5 RSPH6A DGCR8 ALOX12 ZNF710	1.54e-04	198	92	6	2369_UP
Drug	Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; PC3; HT_HG-U133A	RIN3 NRXN3 POM121L2 CABIN1 ATP10A NEK11	1.54e-04	198	92	6	6326_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	KMT2A POM121L2 NEB FAAP100 ZFX ZNF710	1.58e-04	199	92	6	3115_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA	PHF20 TRPC5 AKAP13 RO60 DGCR8 CABIN1	1.58e-04	199	92	6	1009_UP
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; PC3; HT_HG-U133A	SLC14A1 DGCR8 CABIN1 FAAP100 NEK11 ZNF710	1.58e-04	199	92	6	4484_DN
Drug	Chrysin [480-40-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	SLC12A6 DRD2 SHANK2 PMEL CABIN1 NEK11	1.58e-04	199	92	6	5505_UP
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	DRD2 POM121L2 RO60 NEB FAAP100 EPN2	1.58e-04	199	92	6	2147_DN
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A	SHANK2 PMEL HCFC1 ZFX ZNF710 VDR	1.58e-04	199	92	6	5412_UP
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A	AKAP6 RIN3 SLC14A1 POM121L2 DGCR8 ATP10A	1.58e-04	199	92	6	2297_UP
Drug	Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DRD2 SHANK2 TRPC5 KAT6A HCFC1 ALOX12	1.58e-04	199	92	6	3306_UP
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A	AKAP6 DRD2 SHANK2 SLC14A1 ARHGAP44 ANKH	1.62e-04	200	92	6	3760_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	DRD2 TRPC5 KAT6A NEB NEK11 ZNF710	1.62e-04	200	92	6	3036_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	KAT6A RO60 DGCR8 CBL HCFC1 ZFX	1.62e-04	200	92	6	5264_DN
Drug	chrysene	TOX4 PIEZO1 EIF4G1 MKI67 RASGEF1C MUC16 SHISA2 NEB DICER1 AREG ZNF710 CDHR4	1.99e-04	871	92	12	ctd:C031180
Disease	congenital heart disease (implicated_via_orthology)	KMT2A HCFC1 AXIN2 SON	5.51e-05	69	88	4	DOID:1682 (implicated_via_orthology)
Disease	mucositis (biomarker_via_orthology)	MKI67 MUC4	8.74e-05	5	88	2	DOID:0080178 (biomarker_via_orthology)
Disease	Child Development Disorders, Specific	CNTN4 DRD2 CBL	8.85e-05	29	88	3	C0085997
Disease	Child Development Deviations	CNTN4 DRD2 CBL	8.85e-05	29	88	3	C0085996
Disease	Bipolar Disorder	SLC12A6 CNTN4 DRD2 SHANK2 PDE9A SLC1A1 ALOX12 VDR	9.13e-05	477	88	8	C0005586
Disease	hair colour measurement	FREM2 RIN3 PIEZO1 AKAP13 HERC2 ATP10A AREG AXIN2 PPP6R3	9.26e-05	615	88	9	EFO_0007822
Disease	autism spectrum disorder (implicated_via_orthology)	NRXN3 SHANK2 TRPC5 NBEA DSCAML1	9.43e-05	152	88	5	DOID:0060041 (implicated_via_orthology)
Disease	Developmental Disabilities	CNTN4 DRD2 CBL	9.82e-05	30	88	3	C0008073
Disease	chronic obstructive pulmonary disease	AKAP6 RIN3 ARHGEF28 RPAP1 PIEZO1 RASGEF1C POM121L2 CHRNB4 TWIST1	2.14e-04	688	88	9	EFO_0000341
Disease	Cornelia De Lange Syndrome	KMT2A RAD21	2.43e-04	8	88	2	C0270972
Disease	diffuse large B-cell lymphoma (is_marker_for)	MKI67 DICER1	2.43e-04	8	88	2	DOID:0050745 (is_marker_for)
Disease	Colorectal Carcinoma	AKAP6 CNTN4 RPAP1 MAP1B EIF4G1 MKI67 ZNF217 DSCAML1 AXIN2	2.49e-04	702	88	9	C0009402
Disease	FEV/FEC ratio	AKAP6 FREM2 ARHGEF28 RPAP1 PDE9A U2SURP RASGEF1C RSPH6A NEB GTF2IRD1 CDHR4 TWIST1	2.83e-04	1228	88	12	EFO_0004713
Disease	Pituitary Adenoma	DRD2 DICER1	3.12e-04	9	88	2	C0032000
Disease	inflammatory biomarker measurement, YKL40 measurement	CNTN4 ARHGEF28 VDR	4.81e-04	51	88	3	EFO_0004869, EFO_0004872
Disease	sialic acid-binding Ig-like lectin 14 measurement	ARHGEF28 SIGLEC5	5.69e-04	12	88	2	EFO_0008284
Disease	nicotine dependence (implicated_via_orthology)	DRD2 TRPC5	5.69e-04	12	88	2	DOID:0050742 (implicated_via_orthology)
Disease	Peripheral Nervous System Diseases	SLC12A6 MKI67 ALOX12	5.70e-04	54	88	3	C4721453
Disease	cholangiocarcinoma (is_marker_for)	MKI67 MUC16 MUC4	9.36e-04	64	88	3	DOID:4947 (is_marker_for)
Disease	Schizoaffective disorder-bipolar type	NRXN3 RAD21	1.03e-03	16	88	2	EFO_0009965
Disease	breast cancer (is_implicated_in)	MKI67 AREG TWIST1 VDR	1.07e-03	150	88	4	DOID:1612 (is_implicated_in)
Disease	gait measurement	AKAP6 DRD2 NRXN3 POM121L2	1.07e-03	150	88	4	EFO_0007680
Disease	Autistic Disorder	CNTN4 NRXN3 SHANK2 NBEA ATP10A	1.12e-03	261	88	5	C0004352
Disease	response to phenylephrine	ATP10A NEK11	1.16e-03	17	88	2	EFO_0010152
Disease	Alcoholic Intoxication, Chronic	CNTN4 DRD2 NRXN3 DSCAML1 CHRNB4	1.26e-03	268	88	5	C0001973
Disease	Myeloid Leukemia	KMT2A RAD21	1.30e-03	18	88	2	C0023470
Disease	Leukemia, Monocytic, Chronic	KMT2A RAD21	1.30e-03	18	88	2	C0023466
Disease	Endometrioma	SLC1A1 ANKH DICER1 AREG	1.39e-03	161	88	4	C0269102
Disease	Endometriosis	SLC1A1 ANKH DICER1 AREG	1.39e-03	161	88	4	C0014175
Disease	DiGeorge syndrome (implicated_via_orthology)	KAT6A DICER1	1.45e-03	19	88	2	DOID:11198 (implicated_via_orthology)
Disease	bone density, lean body mass	RIN3 PPP6R3	1.78e-03	21	88	2	EFO_0003923, EFO_0004995
Disease	Obsessive-compulsive trait	MUC22 NEK11	1.78e-03	21	88	2	HP_0008770
Disease	Hodgkins lymphoma	ZNF526 ARHGEF28 SHANK2	1.91e-03	82	88	3	EFO_0000183
Disease	Stomach Neoplasms	CLCN3 KMT2A AREG AXIN2 TWIST1	1.98e-03	297	88	5	C0038356
Disease	acute myeloid leukemia (is_implicated_in)	KAT6A KMT2A CBL	2.05e-03	84	88	3	DOID:9119 (is_implicated_in)
Disease	Malignant neoplasm of stomach	CLCN3 KMT2A AREG AXIN2 TWIST1	2.07e-03	300	88	5	C0024623
Disease	lung adenocarcinoma (is_marker_for)	MKI67 MUC4 CHRNB4	2.12e-03	85	88	3	DOID:3910 (is_marker_for)
Disease	Epilepsy, Benign Psychomotor, Childhood	SLC1A1 VDR	2.14e-03	23	88	2	C0393672
Disease	Epilepsy, Lateral Temporal	SLC1A1 VDR	2.14e-03	23	88	2	C0393682
Disease	Uncinate Epilepsy	SLC1A1 VDR	2.14e-03	23	88	2	C0014558
Disease	Epilepsy, Temporal Lobe	SLC1A1 VDR	2.14e-03	23	88	2	C0014556
Disease	suicidal ideation, suicide behaviour	DRD2 POM121L2	2.33e-03	24	88	2	EFO_0004320, EFO_0007623
Disease	hair color	CNTN4 FREM2 HERC2 AREG AXIN2	2.42e-03	311	88	5	EFO_0003924
Disease	Prostatic Neoplasms	KAT6A KMT2A AKAP13 RPRD2 SMARCAD1 MUC4 VDR	2.47e-03	616	88	7	C0033578
Disease	Malignant neoplasm of prostate	KAT6A KMT2A AKAP13 RPRD2 SMARCAD1 MUC4 VDR	2.47e-03	616	88	7	C0376358
Disease	forced expiratory volume	RIN3 NRXN3 PIEZO1 RASGEF1C POM121L2 RPRD2 RBM20 TWIST1	2.47e-03	789	88	8	EFO_0004314
Disease	large artery stroke, coronary artery disease	CHRNB4 TWIST1	2.52e-03	25	88	2	EFO_0001645, EFO_0005524
Disease	breast cancer, lung cancer	RIN3 POM121L2	2.52e-03	25	88	2	MONDO_0007254, MONDO_0008903
Disease	osteoarthritis, hip	PIEZO1 RPRD2 HERC2	2.66e-03	92	88	3	EFO_1000786
Disease	Ischemic stroke	PDE9A SLC14A1 SLC1A1 ZNF691 TWIST1	2.88e-03	324	88	5	HP_0002140
Disease	refractive error	AKAP6 SLC12A6 NBEA FAAP100 DSCAML1	2.96e-03	326	88	5	MONDO_0004892

Protein segments in the cluster

Peptide	Gene	Start	Entry
MEAMAASTSLPDPGD	VDR	1	P11473
MTPTASMDDFTPSGE	CHRNB4	186	P30926
MEEMSGESVVSSAVP	KCTD10	1	Q9H3F6
DLMSSAVPMTPEDPS	AASDHPPT	276	Q9NRN7
EMSSGSEISPVSEMP	AREG	56	P15514
PCTATSGPMSEMSSI	ADGRG4	1551	Q8IZF6
MMTAQDPSSAPETDG	AKAP13	301	Q12802
DPTRVMVPPSSMDVT	CNTN4	496	Q8IWV2
MVPPSSMDVTVGESI	CNTN4	501	Q8IWV2
SMSMTDSSVDGIPPY	AXIN2	311	Q9Y2T1
SDHPSDGETSVQPMM	DGCR8	271	Q8WYQ5
TSDGSPVMAVMPGTT	DICER1	1251	Q9UPY3
VPSTMTPMLVTDTEA	CDHR4	666	A6H8M9
ASGEPSTVDMSMPVR	ATP10A	1366	O60312
SASTSCPSDMDVEMP	RBM20	986	Q5T481
VDPVEPMPTMTDQTT	RAD21	281	O60216
MGSSPSTESFIMEDV	ARHGEF28	796	Q8N1W1
VMGTGEPMDTSEAAA	HCFC1	1646	P51610
STTTPNPEVGMSTMD	MUC16	3551	Q8WXI7
NPEVGMSTMDSTPAT	MUC16	3556	Q8WXI7
TSMPGSSEITRIEME	MUC16	6636	Q8WXI7
SGMTTPMSRGPEDVS	MUC16	8826	Q8WXI7
METAPPDEMTTSFPS	MUC4	111	Q99102
TVSSDSPLKMETPGM	MUC4	4251	Q99102
ISSEPTPMDEMSTPR	MAP1B	1126	P46821
TPMDEMSTPRDVMSD	MAP1B	1131	P46821
MTTDDTEVPAMTLAP	MUC20	36	Q8N307
MGSETTMASTIGPET	MUC22	551	E2RYF6
PSDASAMASPMNGEE	HERC2	3436	O95714
PGPGVESMAVASMTS	EPN2	581	O95208
ETVGSMTPDIMETVT	GARIN4	576	Q8IYT1
VSSPMDTVTEAGMAI	IMPDH2	66	P12268
EEMSSMADVTFPSVP	FREM2	2361	Q5SZK8
TDDAMVSIDPTMPAN	PDE9A	56	O76083
TSMPPEMSTTVMETT	NRXN3	1276	Q9Y4C0
ETTMPPSETATSETM	DEFB125	131	Q8N687
DTKTITTMAEDMSPG	NEK11	541	Q8NG66
TPGPSEESMTDEKTT	MKI67	1111	P46013
PTTKEDVTMATVMGS	ALOX12	566	P18054
LDSEMPGPARMTTES	FAAP100	436	Q0VG06
MSSENTTGPPSSMDR	ITPRID2	676	P28290
TSMQPTEAMGEEPSR	ICAM3	531	P32942
EDMTPTEQTPRGSME	PRICKLE2	531	Q7Z3G6
NMETSPMMDVPSVSD	KAT6A	1526	Q92794
VTPAEEMGDTAMIST	BOD1L1	2281	Q8NFC6
EEGMSETPMLPSSLM	CABIN1	876	Q9Y6J0
NADSMTSMSTPSEPG	DSCAML1	1851	Q8TD84
EGEDSAMTDMPPTEE	ANKH	466	Q9HCJ1
AMTDMPPTEEVTDIV	ANKH	471	Q9HCJ1
MQVPTAEEMSSLTPE	BRSK1	571	Q8TDC3
PGDTMTTIQMSVEES	EIF4G1	286	Q04637
TPSVMETNTSVLGPM	KMT2A	3111	Q03164
SMSMNSSPLVGPECD	CBL	646	P22681
AQELEMEMLSSTSPP	DRD2	276	P14416
PSPTSEEMTDSMPGH	GTF2IRD1	511	Q9UHL9
GTPTQDEMMDKPTSS	RPRD2	731	Q5VT52
VPETSRSEPMSEMSG	SLC12A6	51	Q9UHW9
EVETVMSEVSGFPMP	BYSL	161	Q13895
PPSDPEMNMTEESFT	SLC1A1	171	P43005
SSDTDSPATMGGMVA	LIPE	241	Q05469
TSPISTDGMAEELTM	PRDM4	201	Q9UKN5
DLGVTTSVPEVPMME	RIN3	726	Q8TB24
GSSSLTSEDPVTMMD	HSF2	331	Q03933
CPSMGENTMKTEPTS	PHF20	401	Q9BVI0
MMAVTKEAPETDTSP	MRPS31	261	Q92665
ETMSMPQLTVPASGS	RTL9	521	Q8NET4
SGPEIMEMSDPTVEE	RSPH6A	671	Q9H0K4
MTTVDEGDEGSMPAD	SMARCAD1	1001	Q9H4L7
TSMPPEMSTTVMETT	NRXN3	271	Q9HDB5
VAPMPEDSAENMSIT	NBEA	1871	Q8NFP9
EDSEPSTGMNYTPSM	SLC9B2	11	Q86UD5
MDDEDPIMGTITSGS	SIGLEC5	476	O15389
METIPMIPSASTSRG	SHISA2	161	Q6UWI4
SVESMITTLDPGMAP	PRRC1	236	Q96M27
GSDVFEEPMSGMSEA	SUPT7L	361	O94864
EEPMSGMSEAGIPQS	SUPT7L	366	O94864
TAPVQMPTAESTGMT	PMEL	361	P40967
VSEVMGTTLAEMSTP	PMEL	381	P40967
GTTLAEMSTPEATGM	PMEL	386	P40967
EMSTPEATGMTPAEV	PMEL	391	P40967
SDEMVPCPVTTDMTL	RO60	416	P10155
SSPQSTEAPMLDGMS	ARHGAP44	751	Q17R89
DESGIIMTGPDMSPT	POM121L2	901	Q96KW2
MPRSPTSSEDEMAQS	SHANK2	1	Q9UPX8
MDASGPSDSDMPSRT	U2SURP	31	O15042
TDASPMAINMTPTVE	AKAP6	21	Q13023
DMSPFTVTDHTPMEI	CLCN3	756	P51790
TSPIPEMEAMSPTTQ	C11orf24	311	Q96F05
EMLPLSSEGSEMGSE	ZNF691	21	Q5VV52
NMTDTGISPMSTRDP	SAGE1	231	Q9NXZ1
MPQTLSASDMVTPGS	RASGEF1C	1	Q8N431
DSQDPMMELTGTDPS	ZNF710	606	Q8N1W2
TPSGLSPTDTMGTAM	RPAP1	1116	Q9BWH6
MEDSPTMVRVDSPTM	SLC14A1	1	Q13336
GSSGMTMDTESEIDP	ZFX	226	P17010
PEVIGSSLGSPMEME	ZNF217	21	O75362
SPGAVEMSTPMSAEM	ZNF526	16	Q8TF50
MSEPSSEPMYTISDG	TRPC5	856	Q9UL62
AEEPLSSMTDDMGSP	PIEZO1	1596	Q92508
PVEMETSTEPMDPLT	PPP6R3	741	Q5H9R7
MMQDVSSSPVSPADD	TWIST1	1	Q15672
VTCMVSETPAMSAEP	SON	1281	P18583
EPPVMSETAETFDSM	SON	1301	P18583
PVTIDVPMTDMTSGL	TOX4	121	O94842
EDIPIVPTTSGTMME	PPIP5K1	376	Q6PFW1
PDTVKFTSVPDSMGM	NEB	1476	P20929